Boiron USA (BOI) Stock Price & News

BOI:EPA

Boiron USA

€ १८.७०

+१.०८%

(+०.२०) 1D

अक्टोबर २९, १७:३५:१४ GMT+१ · EUR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for BOI...

Open

€ १८.४५

High

€ १८.७०

Low

€ १८.४५

Mkt. cap

३१.७६ करोड

Avg. vol.

६.९२ हजार

Volume

१.६७ हजार

P/E ratio

१२.४०

52-wk high

€ ३२.२५

52-wk low

€ १६.९०

EPS

€ १.५१

Shares outstanding

१.७५ करोड

No. of employees

३ हजार

Open

€ १८.४५

High

€ १८.७०

Low

€ १८.४५

Mkt. cap

३१.७६ करोड

Avg. vol.

६.९२ हजार

Volume

१.६७ हजार

P/E ratio

१२.४०

52-wk high

€ ३२.२५

52-wk low

€ १६.९०

EPS

€ १.५१

Shares outstanding

१.७५ करोड

No. of employees

३ हजार

Related stocks

Compagnie des Alpes SA

News stories

From web sources and news partners

Investing.com

५० मिनेट पहिले

U.S. stock futures sink, Nasdaq down 2% as Amazon, Intel earnings underwhelm

Moomoo

४३ मिनेट पहिले

Dow Jones Top Markets Headlines at 9 PM ET: U.S. Stocks Fall as Alphabet Slide Weighs on AI Optimism | Ukraine ...

www.tokenpost.com

५२ मिनेट पहिले

ServiceNow Tumbles 26.95% as AI-Linked Stocks Fall at U.S. Close

Yahoo Finance

१ घण्टा पहिले

Bitcoin Is Beating the S&P 500, so Why Is $85,000 Still Out of Reach?

Profile

Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index. In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations. Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs". Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia

About Boiron USA

CEO-

Employees२.६२ हजार

Founded१९३२ जुन ७

Headquarters-

Sector-

Websiteboiron.fr

Revenue

Net income

All values in EUR	२०२५ सेप्टेम्बर	२०२५ डिसेम्बर	२०२६ मार्च	२०२६ जुन
Revenue	१२.७७ करोड	१२.७७ करोड	१२.०२ करोड	१२.०२ करोड
Cost of goods sold	३.५४ करोड	३.५४ करोड	३.३५ करोड	३.३५ करोड
Cost of revenue	३.५४ करोड	३.५४ करोड	३.३५ करोड	३.३५ करोड
Research and development expenses	१५.६० लाख	१५.६० लाख	१४.४० लाख	१४.४० लाख
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	७.९३ करोड	७.९३ करोड	८.०० करोड	८.०० करोड
Operating expense	७.७५ करोड	७.७५ करोड	८.१९ करोड	८.१९ करोड
Total operating expenses	११.२९ करोड	११.२९ करोड	११.५४ करोड	११.५४ करोड
Operating income	१.४८ करोड	१.४८ करोड	४७.५५ लाख	४७.५५ लाख
Other non operating income	-११.२८ लाख	-११.२८ लाख	-२२.९१ लाख	-२२.९१ लाख
EBT including unusual items	१.३८ करोड	१.३८ करोड	४०.२० लाख	४०.२० लाख
EBT excluding unusual items	१.३२ करोड	१.३२ करोड	२७.५२ लाख	२७.५२ लाख
Income tax expense	३१.७६ लाख	३१.७६ लाख	१५.६४ लाख	१५.६४ लाख
Effective tax rate	२२.९९%	२२.९९%	३८.९०%	३८.९०%
Other operating expenses	-३३.०४ लाख	-३३.०४ लाख	४.८८ लाख	४.८८ लाख
Net income	१.०६ करोड	१.०६ करोड	२४.५५ लाख	२४.५५ लाख
Net profit margin	८.३३%	८.३३%	२.०४%	२.०४%
Earnings per share	-	-	-	-
Interest and investment income	६.५३ लाख	६.५३ लाख	६.३६ लाख	६.३६ लाख
Interest expense	-३.३५ लाख	-३.३५ लाख	-४.१० लाख	-४.१० लाख
Net interest expenses	३.१८ लाख	३.१८ लाख	२.२६ लाख	२.२६ लाख
Depreciation and amortization charges	-	-	-	-
EBITDA	१.८१ करोड	१.८१ करोड	१.१२ करोड	१.१२ करोड
Gain or loss from assets sale	-४.४६ लाख	-४.४६ लाख	-	-

Ask anything